Letter to the Editor

Vitamin D3 Administration to Patients with Confirmed COVID-19

1. Zhang H, Penninger JM, Li Y et al (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: mo-lecular mechanisms and potential thera-peutic target. Intensive Care Med, 46:586-90.
2. Kuba K, Imai Y, Rao S, et al (2005). A cru-cial role of angiotensin converting en-zyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med, 11:875-9.
3. Batlle D, Wysocki J, Satchell K (2020). Solu-ble angiotensin-converting enzyme 2: a potential approach for coronavirus infec-tion therapy? Clin Sci (Lond), 134:543-5.
4. Lin M, Gao P, Zhao T, et al (2016). Calcitri-ol regulates angiotensin-converting en-zyme and angiotensin converting-enzyme 2 in diabetic kidney disease. Mol Biol Rep, 43:397-406.
5. Cui C, Xu P, Li G, et al (2019). Vitamin D receptor activation regulates microglia po-larization and oxidative stress in sponta-neously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol, 26:101295.
6. Xu J, Yang J, Chen J, et al (2017). Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the reninangiotensin system. Mol Med Rep, 16:7432-8.
7. Bryson KJ, Nash AA, Norval M (2014). Does vitamin D protect against respirato-ry viral infections? Epidemiol Infect, 142:1789-801.
8. Grant WB, Lahore H, McDonnell SL, et al (2020). Evidence that Vitamin D Supple-mentation Could Reduce Risk of Influen-za and COVID-19 Infections and Deaths. Nutrients, 12(4): E988.
Files
IssueVol 49 No Supple 1 (2020) QRcode
SectionLetter to the Editor
Published2020-04-28
DOI https://doi.org/10.18502/ijph.v49iS1.3690

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
RASHEDI J, MAHDAVI POOR B, ASGHARZADEH M. Vitamin D3 Administration to Patients with Confirmed COVID-19. Iran J Public Health. 2020;49(Supple 1):141-142.